$GELS News

Gelteq Announces $3.5M Strategic Debt Financing To Expand Commercialization And Clinical Trial Activity

Gelteq shares are trading higher. The company yesterday announced results from a recently completed preclinical study which evaluated medicinal cannabinoids delivery through the Company's proprietary oral gel platform.

Gelteq shares are trading higher. The company yesterday announced results from a recently completed preclinical study which evaluated medicinal cannabinoids delivery through the Company's proprietary oral gel platform.

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED)

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Bank of America, Citigroup And 3 Stocks To Watch Heading Into Wednesday

What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?

Gelteq Announces Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform; Says Formulation Achieved Over 22% Increase In bioavailability

Gelteq Partners With Hong Kong Flag Football Program To Integrate Hydration And Performance Formulations Into Training And Competition Programs

Gelteq Signs 3-Year China Distribution Deal With Mana To Expand Nutritional Product Portfolio; Expects To Derive A Minimum Revenue Of ~$1.3M During The Term Of The Agreement

Gelteq Announces Preclinical Findings Demonstrative Oral Delivery Of Oil-Soluble And Poorly Soluble Drugs Using Co's Gel-Based Platform

Gelteq shares are trading higher after the company announced preclinical results for its proprietary gel formulation.

Gelteq Announces Preclinical Results Showing That Its Proprietary Gel-Based Oral Delivery Formulation Significantly Improves The Bioavailability Of An Antihistamine Compared To A Leading Existing Product

Gelteq shares are trading higher after the company announced commencement of preclinical trial for poorly soluble drugs.

Gelteq Announces Start Of A Preclinical Animal Trial With Monash University To Evaluate Its Proprietary Gel-Based Oral Delivery Technology For Oily And Poorly Soluble Drugs

Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound

Gelteq Signs Product Development, Profit Share Agreement With Melbourne Health To Develop New Products Incorporating High-amylose Maize Starch Butyrylated

Gelteq Technology Powers U.S. Launch Of Healthy Extracts' Nutraceuticals, Marking Transition From R&D To Commercialization

12 Health Care Stocks Moving In Monday's Pre-Market Session

Top Midday Gainers